OB/GYN Clinical Alert – May 1, 2015
May 1, 2015
View Issues
-
OnabotulinumtoxinA and the Bladder
ABSTRACT & COMMENTARY: Healthcare providers should thoroughly counsel patients on the risks associated with onabotulinumtoxinA toxin injections.
-
Using Etonogestrel Implants and LNG-IUDs Past FDA-approved Duration
In this small prospective cohort study, use of the etonogestrel implant and the levonorgestrel intrauterine device for an additional year past their FDA-approved duration was associated with an acceptably low failure rate.
-
Intrauterine Insemination Outcomes Are Not Affected by Sperm Morphology Parameters
Pregnancy rates following intrauterine insemination are not affected by abnormalities of sperm morphology.
-
Diagnostic Concordance in Breast Biopsies
A comparison of breast biopsy diagnosis by clinical pathologists found a 75% concordance with a consensus-derived expert diagnostic interpretation. Concordance was lowest with the diagnosis of atypical, with under-diagnosis noted in 35% of cases.
-
Low-lying Intrauterine Devices: To Remove or Not to Remove?
It is not uncommon that we receive reports from radiology regarding the location of an intrauterine device (IUD) in a patient that we have sent for a pelvic ultrasound examination for an entirely different reason (e.g., an adnexal mass). These incidental findings of low-lying or malpositioned IUDs are a conundrum for the practitioner.